Int Arch Intern Med 2018
DOI: 10.23937/iaim-2017/1710008
|View full text |Cite
|
Sign up to set email alerts
|

Sweet Syndrome Successfully Treated with Ruxolitinib in JAK-2 Positive Myeloproliferative Disorder

Abstract: erythematous and painful skin lesions on his buttocks, lower limbs (Figure 1), flags of ears, and fingers (Figure 2). C-reactive protein was elevated at 200 mg/L and neutrophils count was high at 14 × 10 9 /L.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 10 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?